{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:49:04Z","timestamp":1761061744603},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,27]]},"DOI":"10.7759\/cureus.30757","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T15:09:56Z","timestamp":1666883396000},"source":"Crossref","is-referenced-by-count":3,"title":["Fibro-Adipose Vascular Anomaly: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Bharat","family":"Parmar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavin Ilangovan","family":"G","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alam","family":"Khalil-Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajamani","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ealai A","family":"Parthasarathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moien AB","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-020-01004-z","article-title":"Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway","volume":"15","author":"Hori Y","year":"2020","unstructured":"Hori Y, Hirose K, Aramaki-Hattori N, et al.. Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway. Diagn Pathol. 2020, 15:98. 10.1186\/s13000-020-01004-z","journal-title":"Diagn Pathol"},{"key":"ref2","unstructured":"ISSVA Classification of Vascular Anomalies \u00a92018 International Society for the Study of Vascular Anomalies. (2018). Accessed. September 21, 2022: http:\/\/www.issva.org\/classification."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/BPO.0b013e3182a1f0b8","article-title":"Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity","volume":"34","author":"Alomari AI","year":"2014","unstructured":"Alomari AI, Spencer SA, Arnold RW, et al.. Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity. J Pediatr Orthop. 2014, 34:109-17. 10.1097\/BPO.0b013e3182a1f0b8","journal-title":"J Pediatr Orthop"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20181353","article-title":"Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly","volume":"216","author":"Rodriguez-Laguna L","year":"2019","unstructured":"Rodriguez-Laguna L, Agra N, Iba\u00f1ez K, et al.. Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly. J Exp Med. 2019, 216:407-18. 10.1084\/jem.20181353","journal-title":"J Exp Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2016150197","article-title":"2014 Revised Classification of Vascular Lesions from the International Society for the Study of Vascular Anomalies: radiologic-pathologic update","volume":"36","author":"Merrow AC","year":"2016","unstructured":"Merrow AC, Gupta A, Patel MN, Adams DM. 2014 Revised Classification of Vascular Lesions from the International Society for the Study of Vascular Anomalies: radiologic-pathologic update. Radiographics. 2016, 36:1494-516. 10.1148\/rg.2016150197","journal-title":"Radiographics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-019-04571-6","article-title":"Clinical and imaging features in fibro-adipose vascular anomaly (FAVA)","volume":"50","author":"Amarneh M","year":"2020","unstructured":"Amarneh M, Shaikh R. Clinical and imaging features in fibro-adipose vascular anomaly (FAVA). Pediatr Radiol. 2020, 50:380-7. 10.1007\/s00247-019-04571-6","journal-title":"Pediatr Radiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/JOVA.0000000000000042","article-title":"A comparative review of fibroadipose vascular anomaly and PTEN hamartoma syndrome of the soft tissue: a case review of FAVA and PHOST","volume":"3","author":"Lin JY","year":"2022","unstructured":"Lin JY, Ochmanek, Ochmanek E, Tchanque-Fossuo CN, et al.. A comparative review of fibroadipose vascular anomaly and PTEN hamartoma syndrome of the soft tissue: a case review of FAVA and PHOST. Journal of Vasc Anomalies. 2022, 3:2. 10.1097\/JOVA.0000000000000042","journal-title":"Journal of Vasc Anomalies"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/01241398-199414060-00016","article-title":"Latent onset unilateral toe-walking secondary to hemangioma of the gastrocnemius","volume":"14","author":"Klemme WR","year":"1994","unstructured":"Klemme WR, James P, Skinner SR. Latent onset unilateral toe-walking secondary to hemangioma of the gastrocnemius. J Pediatr Orthop. 1994, 14:773-5. 10.1097\/01241398-199414060-00016","journal-title":"J Pediatr Orthop"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13260","article-title":"Fibroadipose vascular anomaly treated with sirolimus: successful outcome in two patients","volume":"34","author":"Erickson J","year":"2017","unstructured":"Erickson J, McAuliffe W, Blennerhassett L, Halbert A. Fibroadipose vascular anomaly treated with sirolimus: successful outcome in two patients. Pediatr Dermatol. 2017, 34:e317-20. 10.1111\/pde.13260","journal-title":"Pediatr Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-016-3576-0","article-title":"Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option","volume":"46","author":"Shaikh R","year":"2016","unstructured":"Shaikh R, Alomari AI, Kerr CL, Miller P, Spencer SA. Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option. Pediatr Radiol. 2016, 46:1179-86. 10.1007\/s00247-016-3576-0","journal-title":"Pediatr Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00238-019-01620-z","article-title":"Fibro-adipose vascular malformation (FAVA) in forearm: a successful surgical approach and literature review","volume":"43","author":"L\u00f3pez S","year":"2020","unstructured":"L\u00f3pez S, Estupi\u00f1\u00e1n AI, Baselga E, Carmen V, Fumagalli C, Valverde S, Masi\u00e0 J. Fibro-adipose vascular malformation (FAVA) in forearm: a successful surgical approach and literature review. Eur J Plast Surg. 2020, 43:6. 10.1007\/s00238-019-01620-z","journal-title":"Eur J Plast Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/120734-fibro-adipose-vascular-anomaly-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:41Z","timestamp":1707507761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/120734-fibro-adipose-vascular-anomaly-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.30757","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,27]]}}}